Xtant Medical Holdings
XTNT
28 hedge funds and large institutions have $99.3M invested in Xtant Medical Holdings in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 2 closing their positions.
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
200% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 4
47% more funds holding
Funds holding: 19 → 28 (+9)
31% more capital invested
Capital invested by funds: $76M → $99.3M (+$23.3M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5.05% less ownership
Funds ownership: 75.08% → 70.04% (-5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.29M |
| 2 |
ACM
Altium Capital Management
New York
|
+$2.9M |
| 3 |
AE
AMH Equity
Great Neck,
New York
|
+$637K |
| 4 |
AIC
AWM Investment Company
New York
|
+$503K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$254K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CGA
Crescent Grove Advisors
Lake Forest,
Illinois
|
-$53.7K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$23.5K |
| 3 |
MPPLM
Midwest Professional Planners Ltd (MPPL)
Wausau,
Wisconsin
|
-$5.37K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$913 |
| 5 |
Morgan Stanley
New York
|
-$303 |
XTNT Hedge Fund Activity: Q3 2023 in Review
28 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q3 2023, worth a combined $99.3M — up 31% from $76M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new XTNT positions and 2 closed out — a net gain of 9 holders — while 12 added to existing stakes and 4 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $4.29M. The largest seller was Crescent Grove Advisors, cutting an estimated $53.7K.
- 28 institutional investors held Xtant Medical Holdings (XTNT) as of Q3 2023, up from 19 in Q2 2023.
- Funds reported $99.3M of Xtant Medical Holdings stock for Q3 2023, up 31% quarter-over-quarter.
- 11 funds opened new Xtant Medical Holdings positions in Q3 2023 and 2 closed out, a net change of +9 holders.
- The largest Xtant Medical Holdings buyer in Q3 2023 was Nantahala Capital Management, an estimated $4.29M added.
- The largest Xtant Medical Holdings seller in Q3 2023 was Crescent Grove Advisors, an estimated $53.7K sold.
Based on aggregated 13F filings for Q3 2023.